MARKET

MYCOF

MYCOF

Mydecine Innovations Group Inc
OTCPK
0.411
-0.029
-6.59%
Opening 09:30 02/08 EST
OPEN
--
PREV CLOSE
0.411
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
110.00
52 WEEK LOW
0.050
MARKET CAP
4.58M
P/E (TTM)
-0.1031
1D
5D
1M
3M
1Y
5Y
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
Benzinga · 01/03 14:33
Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More
Benzinga · 12/20/2022 01:23
Psychedelic Company Sale: Mydecine Gets Over $2.5M For Wholly-Owned Tech Subsidiary Business
Benzinga · 12/13/2022 18:47
MYDECINE INNOVATIONS GROUP FILES PROSPECTUS SUPPLEMENT AND ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT
Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular empha...
CNW Group · 11/29/2022 01:38
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
Benzinga · 11/22/2022 00:13
Mydecine Innovations Group Files Prospectus Supplement and Announces Closing Under Share Subscription Agreement
DENVER, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly addres...
GlobeNewswire · 11/21/2022 17:01
Mydecine's Q3 Financials & Update, Sustained Target On Smoking Cessation For Next 12 Months
Benzinga · 11/15/2022 17:25
Mydecine Innovations Group GAAP EPS of -$0.35
Seekingalpha · 11/15/2022 11:23
More
About MYCOF
Mydecine Innovations Group Inc. is a Canada-based biopharma and life sciences company. The Company is focused on the research, development and acceptance of alternative nature-sourced medicine. Its portfolio of companies includes Mydecine Health Sciences (MHS), Mindleap Health Inc. (Mindleap) and NeuroPharm, Inc (NPI). MHS is focused on developing fungtional mushroom products and psychedelic medicines for the consumer and professional healthcare market. NPI is a veterans-focused healthcare company that is developing pharmaceutical and natural health products for mental wellness in vulnerable populations, including veterans, emergency medical services (EMS) personnel and other high-risk constituencies. NPI is developing psilocybin-assisted psychotherapy to treat chronic post-traumatic stress disorder (PTSD). Mindleap offers a digital health platform that enables people connect with mental health specialists, who can help them to develop habits for a healthy mind.

Webull offers kinds of Mydecine Innovations Group Inc stock information, including OTCPK:MYCOF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MYCOF stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MYCOF stock methods without spending real money on the virtual paper trading platform.